Clinical Trials Logo

Filter by:
NCT ID: NCT05538117 Completed - Clinical trials for Acute Coronary Syndrome

Diagnostic Performance of Coronary Calcification Detection on CT Scan

Calci-DT
Start date: August 18, 2022
Phase:
Study type: Observational

thoracic pain is one of the most frequent reasons for consulting the emergency room. Chest pain can be a sign of different pathologies with a wide range of severity, from life-threatening aortic dissection or myocardial infarction to chest pain during an anxiety attack. Efficient triage of patients is therefore a crucial issue for emergency physicians in order not to ignore an acute coronary event requiring early and specific management. The investigators seek to evaluate whether a diagnostic strategy based on a thoracic CT scan to rule out coronary calcifications and a single troponin assay can exclude an acute coronary event with sufficient accuracy compared to usual management.

NCT ID: NCT05538000 Not yet recruiting - Clinical trials for No Metastatic Breast Cancer

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)

EFACog
Start date: May 2024
Phase: N/A
Study type: Interventional

EFACog is a single-center prospective cohort feasibility study conducted on a single group of patients to study the feasibility of a personalized support program by a nurse conducted over 9 months, using face-to-face and telephone interviews. The objective of this support program is to prevent the occurrence of post-chemotherapy cognitive impairment. After a pre-inclusion visit, patients with no pre-existing cognitive impairment will be included in the study and will receive a 9-month follow-up after the first course of chemotherapy. All follow-up visits (telephone or face-to-face) will be scheduled in conjunction with those taking place in the care setting.

NCT ID: NCT05537909 Recruiting - Clinical trials for Aseptic Abscess Syndrome

Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses

ABSCESSBIOT
Start date: September 7, 2021
Phase: N/A
Study type: Interventional

Aseptic abscess syndrome (AA) is a rare entity characterized by the occurrence of deep abscesses with no germ found. Antibiotic therapy is ineffective and they are sensitive to anti-inflammatory treatment with corticosteroids. Gut microbiota is important for the development of the immune system. In Crohn's disease which is frequently associated with AA syndrome, dysbiosis is found but could also be involved in the immune response at a distance from the gut. Stool, blood, saliva and urine samples will be taken from the patients included and their controls in the centers where they are followed. These biological samples will be transported to Clermont Ferrand using the same procedure (transporter and dry ice) where the following analyses will be performed: microbiota on stool and saliva, short chain fatty acids on stool and lymphocyte study on blood.

NCT ID: NCT05537766 Recruiting - Clinical trials for Relapsed/Refractory Hairy Cell Leukemia

Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies

ZUMA-25
Start date: November 1, 2022
Phase: Phase 2
Study type: Interventional

Master protocol: The goal of this master clinical study is to test how well the study drug, brexucabtagene autoleucel, works in participants with rare B-cell malignancies: relapsed/refractory Waldenstrom macroglobulinemia (r/r WM) (Substudy A - no longer recruiting), relapsed/refractory Richter transformation (r/r RT) (Substudy B), relapsed/refractory Burkitt lymphoma (r/r BL) (Substudy C and relapsed/refractory hairy cell leukemia (r/r HCL) (Substudy D - no longer recruiting).

NCT ID: NCT05537727 Recruiting - Hysterectomy Clinical Trials

Robotic MIS With Dexter

Start date: September 27, 2022
Phase:
Study type: Observational

The purpose of this study is to confirm the perioperative and early postoperative safety and clinical performance of the Dexter Robotic System (Dexter Surgical System, Model DM-L6).

NCT ID: NCT05537675 Completed - Clinical trials for Refractory Meningioma

Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction

177Lumen
Start date: October 1, 2022
Phase:
Study type: Observational

Tumor dosimetry with somatostatin receptor-targeted peptide receptor radionuclide therapy (SSTR-targeted PRRT) by 177Lutetium-DOTATATE might contribute to improve follow-up and treatment response of refractory meningiomas. This study aims to evaluate Standard Uptake Value mean (SUVmean) as a tumoral absorbed dose predictive predictive factor and propose semi-automated segmentation method to determine metabolic tumor volume with pretherapeutic 68-Gallium-DOTATOC PET.

NCT ID: NCT05537415 Not yet recruiting - Spousal-Abuse Clinical Trials

Prevalence of Medical Care in an Emergency Structure of the Women Victims of Violence Within the Couple

Spousal-Abuse
Start date: October 1, 2022
Phase:
Study type: Observational

Violence against women within the couple is a major socio-political and public health problem. Indeed, in 2020, 219,000 women were victims of violence within their couple and 102 women were killed by their partner or ex-partner. On average, the number of women aged 18 to 75 who in the course of a year are victims of rape and/or attempted rape is estimated at 94,000 women, and in 47% of cases it is the spouse or the ex-spouse who is the author of the facts. This violence has major health and social consequences: the leading cause of death and disability among women aged 16 to 44 in Europe. In France, a woman dies as a result of domestic violence every 2.5 days and the overall cost of domestic violence in 2012 amounted to 3.6 billion euros in France. A better knowledge of the use of care for wives of victims of violence and their feelings vis-à-vis the medical care in an emergency service will make it possible to identify the problems related to their care based on their feelings. of these patients, to understand why they would not have consulted as a first resort if necessary and to subsequently propose avenues for improvement.

NCT ID: NCT05537194 Completed - Hypoxia Clinical Trials

Effects of Dihydropyridine Calcium Channel Inhibitors on Respiratory Gas Exchanges in the Intensive Care Unit: a Pharmacovigilance Study in VigiBase® and a Comparison With Urapidil

Start date: January 1, 1963
Phase:
Study type: Observational

Due to their effects on hypoxic pulmonary vasoconstriction (HPV), dihydropyridine calcium channel inhibitors (CCI) could lead to hypoxia in patients with a pulmonary shunt. To the present time only preclinical studies and case reports focused on this potential adverse drug reaction. We aimed to assess the reporting association between CCI and hypoxia using the World Health Organization pharmacovigilance database (VigiBase®).

NCT ID: NCT05536973 Active, not recruiting - Clinical trials for Neovascular Age-related Macular Degeneration

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Start date: August 23, 2022
Phase: Phase 2
Study type: Interventional

Neovascular or wet age-related macular degeneration (nAMD) is a degenerative ocular disease associated with the infiltration of abnormal blood vessels in the retina from the underlying choroid layer and is a leading cause of blindness in patients over 65 years of age. The abnormal angiogenic process in nAMD is stimulated and modulated by vascular endothelial growth factor (VEGF). Treatment of nAMD requires frequent intravitreal (IVT) injections of VEGF inhibitors (anti-VEGF) administered every 4-16 weeks. ADVM-022 (AAV.7m8-aflibercept) is a gene therapy product being developed for the treatment of nAMD and offers the potential for sustained intraocular expression of aflibercept following a single IVT injection. ADVM-022 is designed to reduce the current treatment burden which often results in undertreatment and vision loss in patients with nAMD receiving anti-VEGF therapy in clinical practice.

NCT ID: NCT05536869 Recruiting - Clinical trials for Cesarean Section; Dehiscence

Study Comparing a Cohort of Women Having a Classic Caesarean to a Cohort of Women Having a FAUCS Caesarean (FAUCS)

FAUCS
Start date: December 27, 2021
Phase: N/A
Study type: Interventional

The main objective of this study is to compare the time taken to obtain "street fitness" status for women after extraperitoneal cesarean section compared to women after a classic cesarean section.